Dale Chappell, Chief Scientific Officer, 10% Owner at HUMANIGEN, INC (HGEN), sold 926,192 shares at $17.28 ($15.9M) on 2021-06-30, disclosed to the SEC on 2021-07-02.
Open-market sale of $15.9M HGEN by Chief Scientific Officer, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.28 | 16,444 | $284K | 1.8% |
| 2 | $17.28 | 16,444 | $284K | 1.8% |
| 3 | $17.28 | 43,851 | $758K | 4.8% |
| 4 | $17.28 | 43,851 | $758K | 4.8% |
| 5 | $17.28 | 158,961 | $2.7M | 17.3% |
| 6 | $17.28 | 158,961 |
| $2.7M |
| 17.3% |
| 7 | $17.10 | 10,575 | $181K | 1.1% |
| 8 | $17.10 | 10,575 | $181K | 1.1% |
| 9 | $17.10 | 28,198 | $482K | 3.0% |
| 10 | $17.10 | 28,198 | $482K | 3.0% |
| 11 | $17.10 | 102,219 | $1.7M | 11.0% |
| 12 | $17.10 | 102,219 | $1.7M | 11.0% |
| 13 | $17.12 | 7,714 | $132K | 0.8% |
| 14 | $17.12 | 7,714 | $132K | 0.8% |
| 15 | $17.12 | 20,569 | $352K | 2.2% |
| 16 | $17.12 | 20,569 | $352K | 2.2% |
| 17 | $17.12 | 74,565 | $1.3M | 8.0% |
| 18 | $17.12 | 74,565 | $1.3M | 8.0% |
| Total | $17.19 avg | 926,192 | $15.9M | 100% |
| Filing → |
| HGEN | SELL | 2021-06-21 | $18.1M | — | Filing → |
| MRFD | SELL | 2011-03-21 | $12K | — | Filing → |
| MRFD | SELL | 2011-03-14 | $21K | — | Filing → |